Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 102

1.

Perspective: Serum Anticholinergic Drug Level Determinations after 30 Years.

Tune LE.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1189-1190. doi: 10.1016/j.jagp.2016.08.021. Epub 2016 Sep 8. No abstract available.

PMID:
27769834
2.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

3.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

4.

Exploratory analysis of seven Alzheimer's disease genes: disease progression.

Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, Tárraga L, Ballard C, Terrin M, Sherman S, Payami H, López OL, Mintzer JE, Boada M.

Neurobiol Aging. 2013 Apr;34(4):1310.e1-7. doi: 10.1016/j.neurobiolaging.2012.08.014. Epub 2012 Oct 1. Erratum in: Neurobiol Aging. 2014 Nov;35(11):2661.

5.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease.

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study..

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

6.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group..

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

PMID:
21810649
7.

How acute is delirium in nursing homes: an observational study from Wesley Woods at Emory.

Tune LE.

Am J Geriatr Psychiatry. 2008 Sep;16(9):786. doi: 10.1097/JGP.0b013e318181277f. No abstract available.

PMID:
18757772
8.

Nonpharmacological treatment of inappropriate sexual behavior in dementia: the case of the pink panther.

Tune LE, Rosenberg J.

Am J Geriatr Psychiatry. 2008 Jul;16(7):612-3. doi: 10.1097/JGP.0b013e31816ff348. No abstract available.

PMID:
18591581
9.

Safety and efficacy of galantamine in subjects with mild cognitive impairment.

Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS; GAL-INT-11/18 Study Group..

Neurology. 2008 May 27;70(22):2024-35. doi: 10.1212/01.wnl.0000303815.69777.26. Epub 2008 Mar 5. Erratum in: Neurology. 2010 Oct 19;75(16):1485.

PMID:
18322263
10.

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A.

Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31.

PMID:
17974864
11.

A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

Greco KE, Tune LE, Brown FW, Van Horn WA.

J Clin Psychiatry. 2005 Jul;66(7):928-9.

PMID:
16013910
12.

Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications.

Jewart RD, Green J, Lu CJ, Cellar J, Tune LE.

Am J Geriatr Psychiatry. 2005 Apr;13(4):324-8.

PMID:
15845759
13.

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.

Mulsant BH, Gharabawi GM, Bossie CA, Mao L, Martinez RA, Tune LE, Greenspan AJ, Bastean JN, Pollock BG.

J Clin Psychiatry. 2004 Dec;65(12):1708-14.

PMID:
15641877
14.

Dementia management: regulations, rules, and research.

Tune LE, Porsteinsson A, Weinberg A.

J Am Med Dir Assoc. 2003 Jul-Aug;4(4 Suppl):H13-6. Review. No abstract available.

PMID:
12857362
15.

Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.

Lu CJ, Tune LE.

Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):458-61.

PMID:
12837675
16.

Great progress in diagnosis and treatment of dementia.

Tune LE.

Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):388-90. No abstract available.

PMID:
12837667
17.

Schizophrenia in late life.

Tune LE, Salzman C.

Psychiatr Clin North Am. 2003 Mar;26(1):103-13. Review.

PMID:
12683262
18.

Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.

Tune L, Tiseo PJ, Ieni J, Perdomo C, Pratt RD, Votaw JR, Jewart RD, Hoffman JM.

Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):169-77.

PMID:
12611746
19.

Interactive grand rounds: mood stabilizers in dementia.

Nelson JC, Tune LE, Daiello LA, Porsteinsson A.

Geriatrics. 2002 Sep;57(9):suppl 2-5. No abstract available.

PMID:
12271830
20.

The role of antipsychotics in treating delirium.

Tune L.

Curr Psychiatry Rep. 2002 Jun;4(3):209-12.

PMID:
12003684

Supplemental Content

Loading ...
Support Center